Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

p65 antisense oligonucleotides for Crohn's disease

Sep. 27, 1996

Generic dicyclomine HCl now available in the U.S.

Sep. 27, 1996

Clinical trials with Gilead Sciences' GS-840

Sep. 20, 1996

Prokinetic macrolides reported by Abbott

Sep. 20, 1996

Second pivotal trial for Carrington's ulcerative colitis product

Sep. 20, 1996

Novel proton pump inhibitors from Dainippon

Sep. 20, 1996

Gastrointestinal R&D at Daiichi

Sep. 13, 1996

Toyama's gastrointestinal R&D

Sep. 13, 1996

Another Asian approval obtained for SciClone's Zadaxin

Sep. 13, 1996

Anticholestatic drug accepted for review in the treatment of primary biliary cirrhosis

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...